vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and Sunlands Technology Group (STG). Click either name above to swap in a different company.

Sunlands Technology Group is the larger business by last-quarter revenue ($10.1M vs $8.4M, roughly 1.2× BIOHARVEST SCIENCES INC.).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

STG Partners, LLC (STG) is an American private equity firm and based in Menlo Park, California. Its predecessor, Symphony Technology Group ("Symphony") was founded in 2002 by Romesh Wadhwani, William Chisholm, and Bryan Taylor. In 2017, Symphony was reorganized as STG Partners. As of March 2025, STG Partners managed approximately $12 billion in 19 pooled investment vehicle for its clients. The firm itself has less than one billion dollars in assets.

BHST vs STG — Head-to-Head

Bigger by revenue
STG
STG
1.2× larger
STG
$10.1M
$8.4M
BHST

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
BHST
BHST
STG
STG
Revenue
$8.4M
$10.1M
Net Profit
$2.4M
Gross Margin
60.3%
88.5%
Operating Margin
26.5%
Net Margin
24.0%
Revenue YoY
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
STG
STG
Q3 25
$8.4M
$10.1M
Q2 25
$8.1M
$9.3M
Q1 25
$7.7M
Q4 24
$9.7M
Q3 24
$6.5M
Q2 24
$6.0M
$10.0M
Q3 23
$9.9M
Q2 23
$10.0M
Net Profit
BHST
BHST
STG
STG
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
Q4 24
$1.8M
Q3 24
Q2 24
$2.2M
Q3 23
$2.5M
Q2 23
$3.3M
Gross Margin
BHST
BHST
STG
STG
Q3 25
60.3%
88.5%
Q2 25
60.0%
85.2%
Q1 25
58.2%
Q4 24
83.3%
Q3 24
Q2 24
85.2%
Q3 23
87.8%
Q2 23
88.7%
Operating Margin
BHST
BHST
STG
STG
Q3 25
26.5%
Q2 25
15.2%
Q1 25
Q4 24
13.4%
Q3 24
Q2 24
Q3 23
23.3%
Q2 23
29.6%
Net Margin
BHST
BHST
STG
STG
Q3 25
24.0%
Q2 25
15.4%
Q1 25
Q4 24
18.2%
Q3 24
Q2 24
21.5%
Q3 23
25.1%
Q2 23
33.0%
EPS (diluted)
BHST
BHST
STG
STG
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$0.31
Q3 23
Q2 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
STG
STG
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$17.7M
Total Assets
$41.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
STG
STG
Q3 25
$15.1M
Q2 25
Q1 25
Q4 24
$15.6M
Q3 24
Q2 24
$18.7M
Q3 23
$16.5M
Q2 23
Total Debt
BHST
BHST
STG
STG
Q3 25
Q2 25
Q1 25
Q4 24
$1.5M
Q3 24
Q2 24
$1.8M
Q3 23
$2.2M
Q2 23
Stockholders' Equity
BHST
BHST
STG
STG
Q3 25
$17.7M
Q2 25
$12.6M
Q1 25
Q4 24
$10.7M
Q3 24
Q2 24
$7.6M
Q3 23
$2.5M
Q2 23
Total Assets
BHST
BHST
STG
STG
Q3 25
$41.2M
Q2 25
$40.3M
Q1 25
Q4 24
$42.4M
Q3 24
Q2 24
$41.3M
Q3 23
$40.0M
Q2 23
Debt / Equity
BHST
BHST
STG
STG
Q3 25
Q2 25
Q1 25
Q4 24
0.14×
Q3 24
Q2 24
0.24×
Q3 23
0.86×
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons